VIVATRONIX
San Jose, CA
- Neuromodulation
- Neurorehabilitation and assistive tech
- Stroke
VIVATRONIX develops xStep, a non-invasive neurotechnology platform that uses targeted spinal neuromodulation alongside movement training to support recovery of movement, sensation, and functional independence. The platform is designed for neurological conditions including spinal cord injury, stroke, cerebral palsy, multiple sclerosis, ALS, and Parkinson’s disease.
What makes VIVATRONIX distinct
- 01Non-invasive spinal neuromodulation without implants or surgery.
- 02Focuses on neuroplasticity-driven neurorestoration rather than compensating for lost function.
- 03Built on clinically validated SCiP and SCONE technologies and designed for integration with rehabilitation therapy.
- 04US FDA 510(k) cleared and CDSCO approved in India, with FDA Breakthrough designation for multiple indications.
- 05Approved by more than 20 hospitals across four continents for clinical trials.
Technology & products
- xStep neurotechnology platform
- Non-invasive spinal neuromodulation
- SCiP technology
- SCONE technology
- Targeted electrical stimulation during functional movement training
Similar companies
About VIVATRONIX
- Focus
- Stroke
- Headquarters
- San Jose, CA